GENE ONLINE|News &
Opinion
Blog

Deals
Startups Oncology
IDEAYA Capitalizes on $120 Million Deal with GSK
2020-06-19
Business Model and Financial Strategy DecisionsLicensing, M&A, partnering, scaling-up, IPO and m
2020-06-15Partner
M&A
Foundation Medicine Fortifies Growing Prominence in Liquid Biopsy Space by Acquiring Lexent Bio
2020-06-15
Legend Biotech Closes Initial Public Offering Raising Big Money
2020-06-10
COVID-19 Vaccine
COVID-19: AstraZeneca Receives $1B from BARDA to Develop Oxford’s Coronavirus Vaccine
2020-05-23
Funding Proteasome
Vividion Inks $135 Million Deal with Roche for Targeted Protein Degraders
2020-05-20
Trials & Approvals
BMS, bluebird bio’s Investigational BCMA CAR-T Therapy Faces Regulatory Setback
2020-05-18
M&A Anti-inflammatory Drugs
AbbVie Completes Acquisition of Botox Manufacturer, Allergan
2020-05-11
Funding
COVID-19 Vaccine: Moderna Gets $483M Funding Boost from BARDA
2020-04-17
Allergic Asthma
LEO Pharma Strikes Deal with Asian Firms to Develop Atopic Dermatitis & Allergic Asthma Drug
2020-04-17
Licensing RNA
Arrakis Signs Lucrative Deal with Roche to Develop RNA Targeting Small Molecules
2020-04-09
Licensing Multiple Myeloma
Kite Pharma Licences Teneobio’s Antibody Platform to Fight Multiple Myeloma
2020-04-03
Licensing PARP Inhibitor
Japan Grants Orphan Drug Designation to Lynparza for Germline BRCA-mutated Pancreatic Cancer
2020-03-25
Trials & Approvals Lung Cancer
Janssen Bags FDA Breakthrough Therapy Designation for Lung Cancer Drug
2020-03-12
M&A Molecular Diagnostics
Thermo Fisher Scientific to Acquire Qiagen in US$ 11.5 Billion Deal
2020-03-03
1 … 43 44 45 46 47
LATEST
Revolutionizing Treatment: ASGCT’s Clinical Trials Spotlight on Immunotherapy, Cancer Vaccines, and Auditory Diseases
2024-05-09
Advancing Health: ASGCT’s Clinical Trials Spotlight on Cell Therapy and Cell-Based Gene Therapy
2024-05-09
Infinitopes’ Article in Peer-Reviewed Journal Seeks to Unlock the Potential of Cancer Vaccines
2024-05-09
Profluent Achieves Human Genome Editing Milestone Using OpenCRISPR-1: The First AI-Generated, Open-Source Gene Editor
2024-05-08
The Gene & Cell Therapy Landscape: Recent Approvals and Upcoming Therapeutics of Interest
2024-05-06
Exploring Key Areas of RNA Therapeutics Development: Your Blueprint for Maximizing ASGCT Content
2024-05-06
Mastering Gene & Cell Therapy: Your Blueprint for Maximizing ASGCT Content
2024-05-06
READ MORE
EVENT
SEE MORE
Newsletter

Subscribe to receive updates.

SIGN UP
Facebook
Youtube
Twitter
Linkedin
About
Explore
More
© 2024 GeneOnline
Privacy Policy | Terms of Service
Privacy Policy | Terms of Service
  • Subscribe to our newsletter and dive into the world of biopharma with us.
SIGN UP
x
Scroll to Top